×
About 8,858 results

ALLMedicine Angina Pectoris Center

Research & Reviews  3,117 results

Tongmai Yangxin pill reduces myocardial no-reflow by regulating apoptosis and activatin...
https://doi.org/10.1016/j.jep.2020.113069
Journal of Ethnopharmacology; Chen R, Chen T et. al.

Jul 3rd, 2020 - Tongmai Yangxin pill (TMYX) is derived from the Zhigancao decoction recorded in Shang han lun by Zhang Zhongjing during the Han dynasty and was further improved by Professor Ruan Shiyi, a cardiovascular expert at Tianjin University of Traditional ...

Prospective partially randomized comparison of clopidogrel loading versus maintenance d...
https://doi.org/10.5414/CP203644
International Journal of Clinical Pharmacology and Therapeutics; Park JH, Kim JS et. al.

Jun 26th, 2020 - Pre-treatment of clopidogrel 600 mg is better than 300 mg loading for reducing periprocedural myocardial infarction (PMI). We aimed to evaluate pre-treatment methods for preventing PMI among patients undergoing conventional coronary angiography (C...

Sex and Age Differences in Patients With Unstable Angina Pectoris: A Single-Center Retr...
https://doi.org/10.1016/j.amjms.2020.05.020
The American Journal of the Medical Sciences; Xu M, Li HW et. al.

Jun 21st, 2020 - Sex and age may affect the pathogenesis of coronary heart disease, such as cardiovascular risk factors, treatment and prognosis, but this information is not well known. This was a single-center retrospective cohort study. Patients with unstable an...

Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blo...
https://doi.org/10.1007/s00380-020-01637-6
Heart and Vessels; Kiyokuni M, Konishi M et. al.

Jun 11th, 2020 - Adiponectin (APN) has cardioprotective properties and bisoprolol has been reported to increase myocardial APN expression and reduce myocardial damage. Administration of landiolol, which has a higher cardio-selectivity and shorter half-life than bi...

Network pharmacology-based therapeutic mechanism of Kuanxiong aerosol for angina pectoris.
https://doi.org/10.1016/j.jep.2020.113079
Journal of Ethnopharmacology; Wu B, Wang G et. al.

Jun 11th, 2020 - Kuanxiong aerosol has been reported to be an effective and safe clinical treatment for angina pectoris (AP). To explore the potential pharmacological mechanism of Kuanxiong aerosol by combined methods of network pharmacology prediction and experim...

see more →

Guidelines  5 results

Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes
https://care.diabetesjournals.org/content/42/11/2019
Diabetes Care;

Aug 31st, 2019 - Oxygen supplementation has been a cornerstone in the initial treatment of individuals with acute coronary syndrome. While consensus for oxygen supplementation exists for patients with hypoxia, oxygen supplementation has also been routinely used in...

Nitroglycerin - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK482382/
Kim,K.,et al

Mar 1st, 2019 - Nitroglycerin is a vasodilatory drug that is used primarily to provide relief from anginal chest pain. Nitroglycerin has been FDA approved since 2000 and was first sold by Pfizer under the brand name Nitrostat. It is currently FDA approved for the...

Recommendations for advancing the care of Canadians living with refractory angina pecto...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723022
The Canadian Journal of Cardiology; McGillion M, L'Allier PL et. al.

Jul 8th, 2009 - Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement.|2009|McGillion M,L'Allier PL,Arthur H,Watt-Watson J,Svorkdal N,|epidemiology,therapy,epidemiology,

Resting Heart Rate in Cardiovascular Disease
https://www.sciencedirect.com/science/article/pii/S0735109707018232
Journal of the American College of Cardiology;

Dec 11th, 2006 - The importance of resting heart rate (HR) as a prognostic factor and potential therapeutic target is not yet generally accepted. Recent large epidemiologic studies have confirmed earlier studies that showed resting HR to be an independent predicto...

KAPSPARGO SPRINKLE (metoprolol succinate)
https://www.kapspargosprinklerx.com

Kapspargo Sprinkle™ extended-release capsules are for the treatment of hypertension, angina pectoris, and heart failure. Learn more here.

see more →

Drugs  1,149 results see all →

Clinicaltrials.gov  4,409 results

Tongmai Yangxin pill reduces myocardial no-reflow by regulating apoptosis and activatin...
https://doi.org/10.1016/j.jep.2020.113069
Journal of Ethnopharmacology; Chen R, Chen T et. al.

Jul 3rd, 2020 - Tongmai Yangxin pill (TMYX) is derived from the Zhigancao decoction recorded in Shang han lun by Zhang Zhongjing during the Han dynasty and was further improved by Professor Ruan Shiyi, a cardiovascular expert at Tianjin University of Traditional ...

Prospective partially randomized comparison of clopidogrel loading versus maintenance d...
https://doi.org/10.5414/CP203644
International Journal of Clinical Pharmacology and Therapeutics; Park JH, Kim JS et. al.

Jun 26th, 2020 - Pre-treatment of clopidogrel 600 mg is better than 300 mg loading for reducing periprocedural myocardial infarction (PMI). We aimed to evaluate pre-treatment methods for preventing PMI among patients undergoing conventional coronary angiography (C...

Metoprolol succinate - metoprolol succinate tablet, extended release-PD-Rx Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=189b6a89-8de8-4a62-a54b-a6c52be870ca

Jun 25th, 2020 - Metoprolol succinate extended-release tablets, metoprolol succinate, is a beta 1-selective adrenoceptor blocking agent. Metoprolol succinate extended-release tablets are indicated for the treatment of: Hypertension,to lower blood pressure. Lowerin...

Nitroglycerin lingual - nitroglycerin lingual spray-HF Acquisition Co LLC, DBA HealthFirst
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a8eb91f6-7f2e-7d57-e053-2995a90a3893

Jun 24th, 2020 - Nitroglycerin Lingual Spray is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.

Sex and Age Differences in Patients With Unstable Angina Pectoris: A Single-Center Retr...
https://doi.org/10.1016/j.amjms.2020.05.020
The American Journal of the Medical Sciences; Xu M, Li HW et. al.

Jun 21st, 2020 - Sex and age may affect the pathogenesis of coronary heart disease, such as cardiovascular risk factors, treatment and prognosis, but this information is not well known. This was a single-center retrospective cohort study. Patients with unstable an...

see more →

News  175 results

Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes
https://care.diabetesjournals.org/content/42/11/2019
Diabetes Care;

Aug 31st, 2019 - Oxygen supplementation has been a cornerstone in the initial treatment of individuals with acute coronary syndrome. While consensus for oxygen supplementation exists for patients with hypoxia, oxygen supplementation has also been routinely used in...

When Coronary CTA Is Most Appropriate for Suspected Heart Disease
https://www.medscape.com/viewarticle/914696

Jun 21st, 2019 - NEW YORK (Reuters Health) - New research helps zero in on which patients with suspected coronary artery disease (CAD) will derive the most benefit from coronary computed tomography angiography (CTA). "Our results indicate that the accuracy of coro...

Cognitive Decline May Accelerate After Ischemic Events
https://www.medscape.com/viewarticle/914656

Jun 18th, 2019 - After a diagnosis of myocardial infarction (MI) or angina pectoris, individuals enrolled in the English Longitudinal Study of Aging (ELSA) showed more accelerated cognitive decline than those who remained free of coronary heart disease (CHD). The ...

Nitroglycerin - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK482382/
Kim,K.,et al

Mar 1st, 2019 - Nitroglycerin is a vasodilatory drug that is used primarily to provide relief from anginal chest pain. Nitroglycerin has been FDA approved since 2000 and was first sold by Pfizer under the brand name Nitrostat. It is currently FDA approved for the...

Cardiovascular Comorbidity Is Common Among Adults With Epilepsy
https://www.mdedge.com/neurology/epilepsyresourcecenter/article/126589/epilepsy-seizures/cardiovascular-comorbidity

Dec 27th, 2016 - HOUSTON—Adults with epilepsy report cardiovascular disease more often than adults without epilepsy, according to research presented at the 70th Annual Meeting of the American Epilepsy Society. In the 2013 US National Health Interview Survey, women.

see more →

Patient Education  3 results see all →